Company Filing History:
Years Active: 2017-2018
Title: Yuting Tang: Innovator in Cardiovascular Treatment
Introduction
Yuting Tang is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of cardiovascular medicine through his innovative research and development of monoclonal antibodies.
Latest Patents
Yuting Tang holds 2 patents related to methods of treating cardiovascular disorders. His latest patents include "Methods of treating cardiovascular disorders with lectin-like oxidized LDL receptor 1 antibodies" and "Lectin-like oxidized LDL receptor 1 antibodies and methods of use." Both inventions focus on monoclonal antibodies that bind to human lectin-like oxidized LDL receptor 1 (LOX-1), offering new pharmaceutical compositions and treatment methods.
Career Highlights
Yuting Tang is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to advance his research and contribute to innovative solutions in the treatment of cardiovascular diseases.
Collaborations
Yuting has collaborated with notable colleagues, including Kurt Alex Heldwein and Jennifer Brogdon, who is a woman. These collaborations have further enriched his research and development efforts.
Conclusion
Yuting Tang's contributions to cardiovascular treatment through his patents and work at Novartis AG highlight his role as an influential inventor in the medical field. His innovative approaches continue to pave the way for advancements in healthcare.